First-pass extracted concept

switch/inverted and orthogonal cytokine receptor engineering strategies

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Receptor engineering strategies, including switch/inverted and orthogonal designs, restrict cytokine signaling to CAR-T cells, thereby enhancing both specificity and safety.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanistic capabilitysupports2025Source 1DOI PubMed

Switch/inverted and orthogonal receptor engineering strategies restrict cytokine signaling to CAR-T cells and thereby enhance specificity and safety.

Claim 2strategy promisesupports2025Source 1DOI PubMed

Cytokine engineering is presented as a promising strategy to overcome major barriers limiting CAR-T efficacy in solid tumors.

Claim 3therapeutic potentialsupports2025Source 1DOI PubMed

Cytokine-engineering strategies have potential to improve therapeutic outcomes in hematologic malignancies and a broad range of solid tumors.

Claim 4translation limitationsupports2025Source 1DOI PubMed

Cytokine-engineering strategies in CAR-T therapy remain in early clinical application because of safety and clinical translation limitations, including uncontrolled cytokine activation risk and manufacturing complexity.